Pulmatrix Inc Sustainability Reports
Pulmatrix, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative inhaled therapies for respiratory and non-pulmonary diseases. The company utilizes its patented iSPERSE dry powder delivery platform to maximize therapeutic efficiency locally while minimizing systemic side effects.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5299002RHCRZ9ST3GN42
FIGI: BBG003TH2QM0
3 reports from 2019 to 2021